High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-06
DOI
10.1038/srep29177
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- La voie de signalisation PI3K-AKT-mTOR : description, développement thérapeutique, résistances, marqueurs prédictifs/pronostiques et applications thérapeutiques en cancérologie
- (2016) Thibault Brotelle et al. BULLETIN DU CANCER
- Cellular and molecular effects of the mTOR inhibitor everolimus
- (2015) U. Saran et al. CLINICAL SCIENCE
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- C5a stimulates the proliferation of breast cancer cells via Akt-dependent RGC-32 gene activation
- (2014) YI LU et al. ONCOLOGY REPORTS
- Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
- (2013) H. Nitta et al. CLINICAL CANCER RESEARCH
- Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
- (2013) Jie Gu et al. LUNG CANCER
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
- (2012) Leticia Corrales et al. JOURNAL OF IMMUNOLOGY
- Clinically relevant fatigue in recurrence-free prostate cancer survivors
- (2011) D. J. Storey et al. ANNALS OF ONCOLOGY
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
- (2011) Maxine Sun et al. EUROPEAN UROLOGY
- Inhibiting the C5–C5a receptor axis
- (2011) Trent M. Woodruff et al. MOLECULAR IMMUNOLOGY
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Diagnostic and Prognostic Molecular Markers for Renal Cell Carcinoma: A Critical Appraisal of the Current State of Research and Clinical Applicability
- (2009) Christian Eichelberg et al. EUROPEAN UROLOGY
- Complement component 5a (C5a)
- (2009) Helga D. Manthey et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of the antitumor immune response by complement
- (2008) Maciej M Markiewski et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started